Dyne Therapeutics DYN
NASDAQ DYN
$17.99 +0.07 (+0.39%)
As of: Nov 11, 2026 · 3:59 PM EST

Dyne Therapeutics (DYN) Invested Capital (2020 - 2026)

Updated

Dyne Therapeutics (DYN) reported Invested Capital of $376.78 million for Q3 2020.

Analysis

Dyne Therapeutics (DYN) Invested Capital (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 89.77 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 126.18 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 76.32 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 98.72 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 45.14 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 68.36 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 39.27 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 151.97 Bn
10 Dyne Therapeutics 3.36 Bn -757.60 Mn - 1.13 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.13 Bn
Jun 30, 2026 901.48 Mn
Mar 31, 2026 1.01 Bn
Dec 31, 2025 85.95 Mn
Sep 30, 2025 790.93 Mn
Jun 30, 2025 670.26 Mn
Dec 31, 2024 151.83 Mn
Dec 31, 2023 60.90 Mn
Dec 31, 2022 33.52 Mn
Sep 30, 2020 376.78 Mn
API Access

Dyne Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=DYN&period=max&api_key=YOUR_API_KEY